Sort
78,016 grants matching “breast cancer”
Rewired Signaling at the Nexus of Melanoma Metastasis and Resistance
$1,104,636Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R35 · FY2022 · CA
DCEG- GWAS Studies
$1,104,589Leonard Freedman · Leidos Biomedical Research, Inc. · N01 · FY2023 · CA
ONTARIO FAMILY REGISTRY FOR STUDIY OF BREAST CANCER RISK
$1,104,485Cancer Care Ontario · U01 · FY2003 · CA
Discovery Expansion and Replication
$1,104,208Brian E Henderson · University Of Southern California · U19 · FY2011 · CA
NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care
$1,103,993Harold John Burstein · Dana-Farber Cancer Inst · UG1 · FY2019 · CA
NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care
$1,103,826Harold John Burstein · Dana-Farber Cancer Inst · UG1 · FY2020 · CA
A Resource for Magnetic Resonance and Optical Imaging
$1,103,748Ravinder Reddy · University Of Pennsylvania · P41 · FY2016 · EB
A Resource for Magnetic Resonance and Optical Imaging
$1,103,748Ravinder Reddy · University Of Pennsylvania · P41 · FY2018 · EB
A Resource for Magnetic Resonance and Optical Imaging
$1,103,748Ravinder Reddy · University Of Pennsylvania · P41 · FY2017 · EB
A Resource for Magnetic Resonance and Optical Imaging
$1,103,748Ravinder Reddy · University Of Pennsylvania · P41 · FY2019 · EB
Environmental and Genetic Risk Factors For Breast Cancer: The Sister Study
$1,103,058Dale P Sandler · National Institute Of Environmental Health Sciences · ZIA · FY2019 · ES
CNR2: A NOVEL THERAPEUTIC TARGET AGAINST AGGRESSIVE AND METASTATIC BREAST CANCER
$1,103,020Ohio State University, The · · FY2017 · Department of the Army
SBIR Phase II: Locating a breast tumor with sub-millimeter accuracy to improve the precision of surgery
$1,102,987Rui Li · Vibronix, Inc. · · FY2019 · TIP
Myeloid TGFbeta signaling in breast cancer metastasis
$1,102,876Li Yang · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Development of a novel MYC inhibitor for cancer therapy
$1,102,729Ben Vollrath · Vortex Therapeutics Inc · R44 · FY2025 · CA
Drugs Targeting Dormant Tumors as Anti-Metastatic Agents
$1,102,521Michael A Ihnat · Dormatarg, Inc. · R44 · FY2011 · CA
MEMBRANE TRAFFIC IN NORMAL AND TRANSFORMED CELLS
$1,102,385Yale University · P01 · FY2001 · CA
Telehealth Research and Innovation for Veterans with Cancer (THRIVE)
$1,102,149Scott E Sherman · New York University School Of Medicine · P50 · FY2023 · CA
Dose-response of aerobic training during total neoadjuvant therapy for locally advanced rectal cancer
$1,101,776Jessica Scott · Sloan-Kettering Inst Can Research · U01 · FY2024 · CA
UIC CENTERS FOR POPULATION HEALTH AND HEALTH DISPARITIES
$1,101,764Elizabeth Ann Calhoun · University Of Illinois At Chicago · P50 · FY2012 · CA
Ultrahigh-Resolution Transformable Clinical PET Camera
$1,101,457University Of Texas Md Anderson Can Ctr · R33 · FY2004 · EB
NHGRI/DIR Cytogenetics and Microscopy Core
$1,101,355Pamela Schwartzberg · National Human Genome Research Institute · ZIC · FY2015 · HG
A Circulating Biomarker for use in Monitoring Metastatic Breast Cancer
$1,101,350Ginette Serrero · A And G Pharmaceutical, Inc. · R44 · FY2018 · CA
Ultrahigh-Resolution Transformable Clinical PET Camera
$1,101,315University Of Texas Md Anderson Can Ctr · R33 · FY2003 · EB
1/3) MMC, VICC, and TSU: Partners in Eliminating Cancer Disparities
$1,101,156Samuel E. Adunyah · Meharry Medical College · U54 · FY2024 · CA